PRESS RELEASE published on 10/24/2025 at 07:46, 4 months 8 days ago WENDEL: Q3 2025 NAV per share at €163.0; Wendel to reach a key milestone in the implementation of its business model transformation Wendel to acquire Committed Advisors, reaching key milestone in business model transformation, with Q3 2025 NAV per share at €163.0 and exclusive negotiations for leading European private asset management platform NAV Per Share Business Model Transformation Wendel Committed Advisors Private Asset Management
PRESS RELEASE published on 10/24/2025 at 07:44, 4 months 8 days ago Ottobock makes follow-on cornerstone investment in NeuroTech company ONWARD® Medical Ottobock strengthens investment in NeuroTech company ONWARD Medical, supporting innovative therapies for spinal cord injury. Companies deepen strategic partnership for joint innovation in NeuroTech, NeuroOrthotics, and Exoskeletons Strategic Partnership Investment Ottobock ONWARD Medical NeuroTech
PRESS RELEASE published on 10/24/2025 at 07:30, 4 months 8 days ago Circus SE Secures Core Technologies Through Six New Defense Patents Circus SE secures core defense technologies with six new patents for autonomous AI robot CA-M, enhancing competitive advantage in global defense market Circus SE Global Market Patents Defense Technologies Autonomous AI Robot
PRESS RELEASE published on 10/24/2025 at 07:30, 4 months 8 days ago Press release: Q3: continued sales and earnings progress
PRESS RELEASE published on 10/24/2025 at 07:05, 4 months 8 days ago LEPAS Elegant Technology, Defined by You: LEPAS Fun Test Drive Interprets a New Paradigm for Intelligent Driving via User Co-Creation LEPAS Fun Test Drive showcases LEPAS's elegant technology through user co-creation for intelligent driving experiences. Events highlight Chery Group's innovative ecosystem vision Intelligent Driving Chery Group LEPAS Elegant Technology User Co-Creation
PRESS RELEASE published on 10/24/2025 at 07:00, 4 months 8 days ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes interim report for the first nine months of 2025, reporting CHF 106 mn net profit. More details at report.bbbiotech.ch/Q325 Financial Results Investment Company Net Profit BB Biotech AG Interim Report
PRESS RELEASE published on 10/24/2025 at 07:00, 4 months 8 days ago BB Biotech Q3 2025: Portfolio outperformance amid early signs of sector recovery BB Biotech AG reports strong Q3 2025 performance with portfolio outperforming Nasdaq Biotech Index, driven by solid net profit, key company milestones, and strategic investments BB Biotech AG Interim Report Sector Recovery Q3 2025 Portfolio Outperformance
REGULATED PRESS RELEASE published on 10/24/2025 at 07:00, 4 months 8 days ago Safran reports third quarter 2025 revenue Safran reports strong Q3 2025 revenue growth of 18.3% reaching €7,852 million. FY guidance raised with solid organic growth in civil engines aftermarket and record LEAP output Safran FY Guidance Q3 2025 Revenue Civil Engines Aftermarket LEAP Output
PRESS RELEASE published on 10/24/2025 at 06:59, 4 months 8 days ago Relief Therapeutics Convenes Extraordinary General Meeting Relief Therapeutics announces Extraordinary General Meeting to seek shareholder approval for business combination with NeuroX Group SA EGM Business Combination Extraordinary General Meeting Relief Therapeutics NeuroX Group SA
PRESS RELEASE published on 10/24/2025 at 06:40, 4 months 8 days ago HBM Healthcare Investments publishes Half-Year Report as at 30 September 2025 with key figures for the first six months of the 2025/2026 financial year HBM Healthcare Investments posts CHF 96 million profit in H1 2025 despite currency challenges, driven by acquisitions and clinical successes. NAV and share price increase Acquisitions HBM Healthcare Investments NAV Profit Clinical Successes
Published on 02/28/2026 at 10:00, 1 day 1 hour ago Storm Exploration Issues Shares to Eabametoong First Nation
Published on 02/28/2026 at 00:10, 1 day 11 hours ago Algo Grande Copper Closes Oversubscribed $6.52 Million Financing and Strengthens Board at AGM
Published on 03/01/2026 at 11:05, 21 minutes ago Acwa Board of Directors names Dr. Samir J. Serhan Chief Executive Officer
Published on 03/01/2026 at 10:30, 56 minutes ago Huawei Launches Comprehensive U6GHz Portfolio to Unlock 5G-A Potential and Pave the Way for 6G
Published on 02/28/2026 at 21:50, 13 hours 36 minutes ago CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BSL RENDITION OF "YOU'LL NEVER WALK ALONE"
Published on 02/28/2026 at 21:20, 14 hours 6 minutes ago Huawei's SuperPoD Portfolio Creates New Option for Global Computing at MWC Barcelona 2026
Published on 02/28/2026 at 21:00, 14 hours 26 minutes ago CARLSBERG MAKES EVERY FAN FEEL PART OF MATCHDAY WITH BRITISH SIGN LANGUAGE RENDITION OF 'YOU'LL NEVER WALK ALONE'
Published on 02/27/2026 at 23:00, 1 day 12 hours ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 1 day 17 hours ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 17:45, 1 day 17 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025
Published on 02/27/2026 at 17:45, 1 day 17 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
Published on 02/27/2026 at 08:45, 2 days 2 hours ago Air Liquide and Holcim sign an agreement to decarbonize cement production with a carbon capture project in Belgium